ONESOURCE — Onesource Specialty Pharma Share Price
Last trade - 00:00- IN₹182.12bn
- IN₹187.79bn
- IN₹1.72bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 44.03 | ||
| Price to Tang. Book | 206.1 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 29.13 | ||
| EV to EBITDA | 257.01 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -8.51% | ||
| Return on Equity | -89.36% | ||
| Operating Margin | -12.08% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | n/a | n/a | n/a | 387.14 | 1,719.19 | n/a | n/a | 344.07% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
OneSource Specialty Pharma Limited is an India-based vertically integrated biopharma service company with the capabilities to develop and manufacture complex biologics, biosimilars and vaccines. It operates as a specialty pharma pure-play contract development and manufacturing organization (CDMO). The Company specializes in prefilled syringes (with or without a safety device), dial and push variable and fixed dose pen injectors, pull push fixed dose pens and autoinjectors. Its integrated services offer comprehensive biologics solutions. It supports the development of complex biologics, including microbial and mammalian cell line biopharmaceuticals, cell and gene therapy and ribonucleic acid (RNA) products. The Company caters to a variety of capsule shapes and sizes, as well as formulations, traditional softgels to enteric coated capsules, vegan alternatives, chewable formats, vaginal pessaries, liposomal capsules, applicaps, and suppositories.
Directors
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- June 12th, 2007
- Public Since
- January 24th, 2025
- No. of Employees
- 525
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 114,436,021
- Address
- BANGALORE, 560076
- Web
- https://www.onesourcecdmo.com/
- Phone
- +91 8067840738
- Contact
- Anurag Bhagania
- Auditors
- Deloitte Haskins & Sells
Upcoming Events for ONESOURCE
Similar to ONESOURCE
Biocon
National Stock Exchange of India
Indo US Bio-Tech
National Stock Exchange of India
Suven Life Sciences
National Stock Exchange of India
Syngene International
National Stock Exchange of India
Take Solutions
National Stock Exchange of India
FAQ
As of Today at 22:26 UTC, shares in Onesource Specialty Pharma are trading at IN₹1,557.90. This share price information is delayed by 15 minutes.
Shares in Onesource Specialty Pharma last closed at IN₹1,557.90 and the price had moved by over the past 365 days. In terms of relative price strength the Onesource Specialty Pharma share price has matched the S&P BSE 100 Index by over the past year.
There is no consensus recommendation for this security.
Find out moreOnesource Specialty Pharma does not currently pay a dividend.
Onesource Specialty Pharma does not currently pay a dividend.
Onesource Specialty Pharma does not currently pay a dividend.
To buy shares in Onesource Specialty Pharma you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹1,557.90, shares in Onesource Specialty Pharma had a market capitalisation of IN₹182.12bn.
Here are the trading details for Onesource Specialty Pharma:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: ONESOURCE
Based on an overall assessment of its quality, value and momentum Onesource Specialty Pharma is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Onesource Specialty Pharma. Over the past six months, its share price has matched the S&P BSE 100 Index by .
As of the last closing price of IN₹1,557.90, shares in Onesource Specialty Pharma were trading +3.06% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Onesource Specialty Pharma PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹1,557.90.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Onesource Specialty Pharma's directors